Are we ready to use PSMA as a theranostic biomarker in clinical practice for patients with breast cancer?

被引：0
|
作者：
Bravaccini, Sara
Virga, Alessandra
Foca, Flavia
Cortecchia, Stefania
Martinelli, Giovanni
Ravaioli, Sara
Tumedei, Maria Maddalena
Matteucci, Federica
Maltoni, Roberta
Paganelli, Giovanni
Poli, Francesca
Mazza, Massimiliano
Nicolini, Fabio
Ulivi, Paola
Sansovini, Maddalena
Caroli, Paola
Puccetti, Maurizio
机构：
[1] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Meldola, Italy
[2] Azienda Unita Sanit Locale AUSL Imola, Imola, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13114
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Are we ready to use TMB in breast cancer clinical practice?
    Ravaioli, Sara
    Limarzi, Francesco
    Tumedei, Maria Maddalena
    Palleschi, Michela
    Maltoni, Roberta
    Bravaccini, Sara
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2020, 69 (10) : 1943 - 1945
  • [2] Are we ready to use TMB in breast cancer clinical practice?
    Sara Ravaioli
    Francesco Limarzi
    Maria Maddalena Tumedei
    Michela Palleschi
    Roberta Maltoni
    Sara Bravaccini
    Cancer Immunology, Immunotherapy, 2020, 69 : 1943 - 1945
  • [3] Spotlight on PSMA as a new theranostic biomarker for breast cancer
    Bravaccini, Sara
    Cortecchia, Stefania
    Foca, Flavia
    Martinelli, Giovanni
    Ravaioli, Sara
    Tumedei, Maria Maddalena
    Matteucci, Federica
    Maltoni, Roberta
    Paganelli, Giovanni
    Poli, Francesca
    Puccetti, Maurizio
    CANCER RESEARCH, 2024, 84 (09)
  • [4] Spotlight on PSMA as a new theranostic biomarker for bladder cancer
    Maria Maddalena Tumedei
    Sara Ravaioli
    Federica Matteucci
    Monica Celli
    Ugo De Giorgi
    Roberta Gunelli
    Maurizio Puccetti
    Giovanni Paganelli
    Sara Bravaccini
    Scientific Reports, 11
  • [5] Spotlight on PSMA as a new theranostic biomarker for bladder cancer
    Tumedei, Maria Maddalena
    Ravaioli, Sara
    Matteucci, Federica
    Celli, Monica
    De Giorgi, Ugo
    Gunelli, Roberta
    Puccetti, Maurizio
    Paganelli, Giovanni
    Bravaccini, Sara
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [6] Are we ready to use oxidative stress in clinical practice?
    Grabowski, Marcin
    EUROPEAN JOURNAL OF LIPID SCIENCE AND TECHNOLOGY, 2013, 115 (02) : 133 - 135
  • [7] Speaker against: Are we ready to use tamoxifen to prevent breast cancer in daily practice?
    Powles, TJ
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S134 - S134
  • [8] Proteomics in cancer research: Are we ready for clinical practice?
    Maes, Evelyne
    Mertens, Inge
    Valkenborg, Dirk
    Pauwels, Patrick
    Rolfo, Christian
    Baggerman, Geert
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2015, 96 (03) : 437 - 448
  • [9] BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?
    Puxeddu, Efisio
    Filetti, Sebastiano
    ENDOCRINE, 2014, 45 (03) : 341 - 343
  • [10] BRAF mutation assessment in papillary thyroid cancer: are we ready to use it in clinical practice?
    Efisio Puxeddu
    Sebastiano Filetti
    Endocrine, 2014, 45 : 341 - 343
12345